Universal-Beteiligungs- und Servicegesellschaft’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.87M Buy
66,572
+156
+0.2% +$8.47K 0.01% 1035
2026
Q1
$3.86M Sell
66,416
-3,708
-5% -$201K 0.01% 982
2025
Q4
$3.24M Buy
70,124
+35,974
+105% +$1.61M 0.01% 1085
2025
Q3
$1.23M Buy
34,150
+8,392
+33% +$278K ﹤0.01% 1477
2025
Q2
$837K Sell
25,758
-81,559
-76% -$2.67M ﹤0.01% 1547
2025
Q1
$4.05M Buy
107,317
+3,634
+4% +$291K 0.01% 885
2024
Q4
$8.49M Buy
+103,683
New +$10.3M 0.02% 584

Other funds holding PCVX

Universal-Beteiligungs- und Servicegesellschaft's PCVX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Vaxcyte (PCVX) stake by 0.23% in Q2 2026, buying an estimated $8.47K and bringing the position to 66,572 shares worth $3.87M. The position accounts for 0.01% of the portfolio, ranked #1035.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in PCVX in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.49M in Q4 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 66,572 shares of Vaxcyte worth $3.87M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 156 Vaxcyte shares in Q2 2026, an estimated $8.47K.
  • Vaxcyte made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1035 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Vaxcyte in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Vaxcyte position peaked at $8.49M in Q4 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.